Tropic Biosciences

Tropic Biosciences is a privately held developer of high-performing commercial varieties of tropical crops that promote cultivation efficiencies, improve sustainable environmental practices and enhance consumer health through its use of cutting-edge genetic editing technologies. Its GEiGS Technology combines gene editing and RNAi in a single platform that enables critical disease resistance and quality improvement traits. The technology caters to the banana production, row crops, livestock, and poultry industries. The company’s partners include Temasek, Agronomics, Polaris Founders Capital, and Excellence Through Stewardship. Headquartered in the UK, Tropical Biosciences has been featured in The Telegraph, Nature, Fast Company, and the Financial Times.